No Data
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.Arcutis Biotherapeutics
Analysts Are Bullish on Top Healthcare Stocks: AdaptHealth (AHCO), Allogene Therapeutics (ALLO)
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Wednesday.Shares of DLocal Limited (NASDAQ:DLO) fell sharply in today's pre-market trading after
Allogene Therapeutics Files For Offering Of Up To 37.93M Shares Of Common Stock
Allogene Therapeutics Files For Offering Of Up To 37.93M Shares Of Common Stock
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)
B. Riley Adjusts Price Target on Allogene Therapeutics to $7 From $10, Keeps Buy Rating
Allogene Therapeutics (ALLO) has an average rating of outperform and price targets ranging from $4.40 to $17, according to analysts polled by Capital IQ. Price: 3.0548, Change: +0.15, Percent Change: